MusclePharm updates guidance after Q2 results

|About: MusclePharm Corp. (MSLP)|By:, SA News Editor

MusclePharm Corp. (OTCQB:MSLP -0.9%) Q2 results: Net Sales: $46.7M (+831%); Gross Profit: $15.6M (+97.5%); Operating Expenses: $15.2M (+42.1%); Operating Income: $479.5K (+118.5%); Net Income: $408.3K (+166.7%); EPS: $0.03 (+108.8%).

Conspicuous by their absence are the company's balance of cash/cash equivalents and CF Ops. The current assets listed on the balance sheet are most certainly dominated by accounts receivable.

2014 Guidance: Net sales: $185M - 195M; EPS: $0.45 - 0.50.